Glioblastoma is among the deadliest cancers, and Mount Sinai researchers are making headway into uncovering mechanisms that could turn that disease around: microglia. These immune cells congregate at the margins of glioblastoma cells, and learning how they contribute to invasion and relapse could mean a better treatment landscape for this lethal cancer.